Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.785 USD | -2.45% | -7.35% | -33.80% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.14B | |
+45.48% | 56.65B | |
-6.42% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.14% | 26.75B | |
-21.38% | 19.03B | |
+0.40% | 12.28B | |
+23.85% | 12.26B | |
+27.70% | 12.04B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- KeyBanc Initiates AbCellera Biologics at Overweight With $6 Price Target, Cites 'Robust' Platform, 'Attractive' Valuation